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d’Immunologie Médicale, Université Libre de Bruxelles, Gosselies, Belgiumc; Ludwig Institute for Cancer Research, Brussels Branch, Brussels, Belgiumd; Department of Host
Defense, Research Institute for Microbial Diseases, Osaka University Yamadaoka, Suita City, Osaka, Japane; INEM-UMR7355, Molecular Immunology, Institute Transgenose,
University and CNRS Orleans, and IIDMM, University of Cape Town, Cape Town, South Africaf; and Laboratoire de Parasitologie, Faculté de Médecine, and Université Libre
de Bruxelles, Brussels, Belgiumg
Brucella spp. are facultative intracellular bacterial pathogens responsible for brucellosis, a worldwide zoonosis that causes abor-
tion in domestic animals and chronic febrile disease associated with serious complications in humans. There is currently no ap-
proved vaccine against human brucellosis, and antibiotic therapy is long and costly. Development of a safe protective vaccine
requires a better understanding of the roles played by components of adaptive immunity in the control of Brucella infection. The
importance of lymphocyte subsets in the control of Brucella growth has been investigated separately by various research groups
and remains unclear or controversial. Here, we used a large panel of genetically deficient mice to compare the importance of B
cells, transporter associated with antigen processing (TAP-1), andmajor histocompatibility complex class II-dependent path-
ways of antigen presentation as well as T helper 1 (Th1), Th2, and Th17-mediated responses on the immune control of Brucella
melitensis 16M infection. We clearly confirmed the key function played by gamma interferon (IFN-)-producing Th1 CD4 T
cells in the control of B. melitensis infection, whereas IFN--producing CD8 T cells or B cell-mediated humoral immunity
plays only a modest role in the clearance of bacteria during primary infection. In the presence of a Th1 response, Th2 or Th17
responses do not really develop or play a positive or negative role during the course of B. melitensis infection. On the whole,
these results could improve our ability to develop protective vaccines or therapeutic treatments against brucellosis.
Brucella (alphaproteobacteria) spp. are facultative intracellularGram-negative coccobacilli that infect humans as well as do-
mestic mammals (cattle, sheep, swine, camels, etc.) and wild
mammals (deer, bison, etc.). Animal infection leads to abortion
and infertility with huge economic costs. Human brucellosis is an
ancient disease mainly transmitted through ingestion, inhalation,
or contact with conjunctiva or skin lesions. It is characterized by
undulant fever that if left untreated can result in chronic and
sometimes lifelong disease, with serious clinical manifestations
(12, 15, 23, 56). Human brucellosis remains a significant public
health concern, with more than 500,000 new human cases re-
ported annually (56). There is currently no available vaccine
against human brucellosis, and all commercially available animal
vaccines are based on live attenuated strains of Brucella (Brucella
melitensisRev.1, B. abortus S19, B. abortusRB51) (20, 54). Despite
their effectiveness, these live vaccines have disadvantages, such as
being infectious and causing disease in humans, interfering with
diagnosis, resulting in abortions when administered to pregnant
animals, and bearing antibiotic resistance (54). Thus, the ideal safe
vaccinewould be a nonreplicating subunit vaccine that specifically
targets the critical aspects of the immune response necessary to
induce immunity. The success of a subunit vaccine is strongly
dependent on the choice of appropriate antigen-presenting
pathways and a suitable adjuvant. Therefore, a better under-
standing of the role played by various lymphocyte subsets dur-
ing infection and the identification of T helper cytokine profiles
associated with protective and counterprotective immune re-
sponse will be very useful for the development of a safe protec-
tive subunit vaccine.
Immune responses toBrucella spp. have been studiedmainly in
mouse models (4, 25). There has been much evidence demon-
strating that the gamma interferon (IFN-)-mediated T helper 1
(Th1) immune response is crucial for the control of Brucella in-
fection. Supplementing infected mice with recombinant IFN-
(66) results in better clearance of B. abortus in the spleen, and
neutralizing endogenous IFN- by administeringmonoclonal an-
tibodies (MAbs) results in decreased control of bacterial growth
(18, 19, 74). Brucella-infectedMyD88-deficient (MyD88/) (10)
and interleukin-12 p40 (IL-12p40)-deficient (IL-12p40/) (37)
C57BL/6 mice display reduced production of IFN- and 10- to
100-fold higher bacterial counts in the spleen. Finally, IFN--de-
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ficient (IFN-/) and interferon responsive factor 1 (IRF-1)-
deficient (IRF-1/) C57BL/6 mice are the rare strains that suc-
cumb to B. abortus (6, 37, 52) or B. melitensis (2) infection. In
contrast, Th2 responses are frequently considered detrimental
during Brucella infection. Indeed, BALB/c mice, which present a
well-known Th2 bias in numerous infectious models (27, 42),
display a reduced ability to control Brucella infection (10, 19, 52).
Moreover, neutralization of IL-4 by MAb can reduce bacterial
counts in somemodels (19). Up to now, studies of the function of
Th17 responses in immunity to Brucella organisms have been
scarce. Nevertheless, Th17 responses have been shown to contrib-
ute to host defense against several intracellular microorganisms,
such asMycobacterium tuberculosis (14, 33, 68).
Adaptive immunity is clearly implicated in the control of
chronic Brucella infection (29). However, the relative roles of B
cells, CD4 cells, and CD8 T cells in protection remain contro-
versial. B cells have been found to be involved in resistance to the
attenuated B. abortus virBmutant (61) and susceptibility to viru-
lent B. abortus (24). Depending on the studies, major histocom-
patibility complex class II (MHC-II)-deficient (MHC-II/)mice
demonstrate that the presence of CD4 T cells appears to be im-
portant (24) or dispensable (55) in the control of infection. CD8
T cells have been shown to play a role in resistance to infection by
depleting CD8 T cells with anti-CD8 monoclonal antibodies
(48, 51, 58) and using 2-microglobulin-deficient (2-micro-
globulin/) mice (55). Both CD4 and CD8 T cells have been
shown to be equally protective in adoptive transfer studies (1).
These results are subject to multiple interpretations.
Using a large panel of gene-deficient mice, we evaluated the con-
tributions of the humoral response and T cell subsets in protective
immunity against B. melitensis, the most frequent cause of human
brucellosis (12). To our knowledge, this study is the first to analyze
the course of infection of virulent Brucella in transporter associated
with antigen processing (TAP-1)-, IL-4-, IL-12p35-, IL-17 receptor
(IL-17R)-, IL-21R-, and IL-22-deficient mice. Our results confirm
the central role ofMHC-II-dependent antigenpresentation toCD4
T cells and the IFN--mediated Th1 response in the control of B.
melitensis infection, whereas the absence of B cells, MHC-I-depen-
dent antigen presentation, and Th2 and Th17 responses appears to
have no important positive or negative impact.
MATERIALS AND METHODS
Ethics statement. The animal handling and procedures of this study
complied with current European legislation (directive 86/609/EEC)
and the corresponding Belgian law, Arrêté Royal Relatif à la Protection
des Animaux d’Expérience du 6 Avril 2010 Publié le 14 Mai 2010
(Royal Decree on the Protection of Experimental Animals of 6 April
2010, published on 14May 2010). The complete protocol was reviewed
and approved by the Animal Welfare Committee of the Facultés Uni-
versitaires Notre-Dame de la Paix (FUNDP; Namur, Belgium) (permit
number 05-558).
Mice and reagents. MyD88/ C57BL/6 mice (31) were obtained
from S. Akira (Osaka University, Osaka, Japan). TAP-1-deficient (TAP-
1/) C57BL/6 mice (70) and MHC-II/ C57BL/6 mice (13) were ob-
tained from Jörg Reimann (University of Ulm, Ulm, Germany). IL-
12p35/ C57BL/6 mice (47) and IL-12p40/ C57BL/6 mice (44) were
obtained from B. Ryffel (University of Orleans, Orleans, France). IL-
21R/C57BL/6 mice (39) were obtained from F. Andris (Université Libre
de Bruxelles, Brussels, Belgium). IL-17R/ C57BL/6 mice (53) and IL-
22/ C57BL/6 mice (38) were obtained from L. Dumoutier (Ludwig Insti-
tute for Cancer Research, Brussels Branch, Brussels, Belgium). Recombinant
activating gene (RAG)-deficient (RAG1/) C57BL/6 mice (49) were ob-
tained from S. Goriely (Université Libre de Bruxelles, Brussels, Belgium).
RAG2c/ C57BL/6 mice (7) were obtained from Michel Y. Braun (Uni-
versité Libre de Bruxelles, Brussels, Belgium). CD28/ and CD40/
C57BL/6mice (30, 64) and B cell-deficient (MuMT/) C57BL/6mice (36)
were purchased from The Jackson Laboratory (Bar Harbor, ME). IL-
12p40/ BALB/c mice (44) were obtained from V. Flamand (Université
Libre de Bruxelles, Brussels, Belgium).Wild-type C57BL/6mice and BALB/c
micewerepurchased fromHarlan(Bicester,UnitedKingdom)andwereused
as controls.Allwild-typeanddeficientmiceused in this studywerebred in the
animal facility of the Gosselies Campus of the Free University of Brussels
(ULB; Brussels, Belgium).
B.melitensis strain 16M (biotype 1, ATCC23456)was initially isolated
from an infected goat and grown in a biosafety level III laboratory facility.
The culture was grown overnight with shaking at 37°C in 2YT medium
(Luria-Bertani broth with a double quantity of yeast extract) to stationary
phase and was washed twice in phosphate-buffered saline (PBS) by cen-
trifugation at 3,500  g for 10 min before use for mouse inoculation as
previously described (10).
Mouse infection. Mice were injected intraperitoneally (i.p.) with the
indicated dose of B. melitensis in 500 l of PBS. Control animals were
injectedwith the same volume of PBS. The infectious doses were validated
by plating serial dilutions of inocula. At selected time intervals, mice were
sacrificed by cervical dislocation. Immediately after the mice were killed,
the spleen was collected for bacterial count and flow cytometry analyses.
Bacterial count. Spleens were recovered in PBS–0.1% Triton X-100
(Sigma). We performed successive serial dilutions in PBS to obtain the
most accurate bacterial count and plated them onto 2YT medium plates.
The numbers of CFU were counted after 4 days of culture at 37°C.
RNA purification and real-time RT-PCR. RNA was extracted from
total spleen tissue. Spleen samples were collected and immediately frozen
and stored at80°C until processing. RNA was then extracted from fro-
zen tissuewithTriPure isolation reagent (Roche) according to the instruc-
tions of the manufacturer. RNA samples were treated with DNase (Fer-
mentas). Reverse transcription (RT) and real-time PCRs were carried out
using LightCycler 480 RNA master hydrolysis probes (one-step proce-
dure) on a LightCycler 480 real-time PCR system (Roche Diagnostics).
Primer sequences are described in Table S1 in the supplemental material.
Cytofluorometric analysis.Aspreviously described (11), spleenswere
harvested, cut in very small pieces, and incubatedwith a cocktail of DNase
I fraction IX (100g/ml; Sigma-Aldrich Chimie SARL, Lyon, France) and
1.6 mg/ml of collagenase (400 Mandl units/ml) at 37°C for 30 min. After
washing, spleen cells were filtered and first incubated in saturating doses
of purified 2.4G2 (anti-mouse Fc receptor; ATCC) in 200 l PBS–0.2%
bovine serum albumin–0.02% NaN3 (fluorescence-activated cell sorter
[FACS] buffer) for 20min on ice to prevent antibody binding to Fc recep-
tor. A total of 3  106 to 5  106 cells were stained on ice with various
fluorescent MAb combinations in FACS buffer and further collected on a
FACSCalibur cytofluorometer (Becton Dickinson, BD). We purchased
the following MAbs from BD Biosciences: fluorescein isothiocyanate
(FITC)-coupled 145-2C11 (anti-CD3ε), FITC-coupled H57-597 (anti-
TCR), phycoerythrin (PE)-coupled RM4-5 (anti-CD4), and PK136
(anti-NK1.1). The cells were analyzed on a FACSCalibur cytofluorometer.
Cells were gated according to size and scatter to eliminate dead cells and
debris from the analysis.
Intracellular cytokine staining. Spleen cells were incubated for 4 h in
RPMI 1640–5% fetal calf serum with 1 l/ml Golgi Plug (BD Pharmin-
gen) at 37°C in 5% CO2. The cells were washed with FACS buffer and
stained for cell surface markers before fixation in PBS–1% paraformalde-
hyde (PFA) for 15 to 20 min on ice. These cells were then permeabilized
for 30min using a saponin-based buffer (10 Perm/Wash [BD Pharmin-
gen] in FACS buffer) and stained with allophycocyanin (APC)-coupled
XMG1.2 (anti-IFN-; BD Biosciences). After final fixation in PBS–1%
PFA, cells were analyzed on a FACScalibur cytofluorometer.No signal was
detectable with control isotypes.
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Statistical analysis. We used a Mann-Whitney or Wilcoxon-Mann-
Whitney test provided by the GraphPad Prism program to statistically
analyze our results. Each group of deficient mice was compared to wild-
type mice. We also compared each group with each other and displayed
the results when required. P values of0.05 were considered to represent
a significant difference.
RESULTS
Major role of CD4 T cells in control of the plateau phase of
chronicB.melitensis infection.The precise role of different com-
ponents of adaptive immunity in the control of Brucella growth is
quite controversial (1, 3, 6, 24, 48, 51, 52, 55, 58, 60, 61). Here, we
compared the course of B. melitensis infection in the spleen of
various C57BL/6 mice rendered genetically deficient for key ele-
ments of adaptive immune response: RAG (T and B cells),
MHC-II (CD4 T cells), TAP-1 (CD8 T cells), and MuMT (B
cells). As an internal control, we used MyD88/mice that pres-
ent well-established susceptibility to B. melitensis infection (10,
71). Wild-type and deficient mice were infected i.p. with 4 104
CFU of B. melitensis (Fig. 1A and B). As expected, RAG deficiency
was correlated with an increased bacterial load in the spleen (Fig.
1A). Comparative analysis of TAP-1/, MHC-II/, and
MuMT/ mice showed a clear unique implication of CD4 T
cells in the late control of B. melitensis infection, as demonstrated
by the fact that at 28 days postinfection (p.i.), only MHC-II/
mice were unable to control the infection. In contrast, at 28 days
p.i., TAP-1/ mice displayed an unchanged CFU count in the
spleen, and as previously reported by Goenka et al. (24),
MuMT/mice exhibited a reduced bacterial load comparedwith
wild-type mice.
IFN- is well-known as a key cytokine that regulates resistance
to Brucella infection (10, 19, 52), as mice deficient for IFN- do
not survive infection (6, 52). In the spleen, early IFN-production
(at 5 days) derives equally fromNK cells, CD4T cells, and CD8
T cells, while later sustained IFN- production (at 12 days) is
mainly dependent on CD4 T cells (10). Using flow cytometry
analyses, we investigated the impact of different targeted genetic
deficiencies on the frequency of IFN--producing cells in the
spleen. It is important to note that the cells were never stimulated
in vitro before intracellular cytokine staining. Thus, the IFN-
detected in these cells derived only from natural in vivo activation
during the course of infection.
At 5 days p.i., a highly significant increase of IFN--positive
(IFN-) cells was observed in RAG/ and MuMT/ mice
compared with wild-type mice (Fig. 2A). In RAG/ mice, this
surprisingly elevated frequency of IFN- cells was mainly due to
NK cells (Fig. 2B; see Fig. S1 in the supplemental material). This
was confirmed by the complete absence of IFN- in the spleens of
RAGc/ mice deficient for NK cells (see Fig. S1 in the supple-
mental material). As previously described by Goenka et al. (24),
MuMT/ mice displayed a higher frequency of IFN--produc-
ing T cells, associatedwith better control of the infection (Fig. 2A).
Despite a severe deficiency in CD4 T or CD8 T cells (see Fig. S2
in the supplemental material), the total frequency of IFN--pro-
ducing cells was not reduced either in MHC-II/ mice or in
TAP-1/mice. Similar results, due to transitory compensations,
have been reported by Das (16) after injection of anti-CD3 anti-
bodies.
At 12 days p.i., only RAG/mice displayed a strongly dimin-
ished frequency of IFN--producing cells, since NK cells were no
longer able to assume IFN- production (Fig. 2A). Interestingly,
at 12 days p.i.,MHC-II/ andTAP-1/mice displayed a similar
frequency of IFN--producing cells, but at 28 days p.i., only
MHC-II/mice failed to control Brucella infection (Fig. 1B). As
expected, IFN- production was taken over by CD8 T cells in
MHC-II/mice (Fig. 2B andC). Note that splenomegaly and the
number of spleen cells (data not shown) were similar in both
strains of infected mice. This strongly suggests that resistance to
Brucella not only is restricted to IFN- production but also re-
quires functional CD4 T cells.
BALB/c mice do not present a Th2 bias during the course of
Brucella melitensis infection. Since the discovery of the Th1 and
Th2 paradigm, resistance to Brucella has been described to be
associated with a Th1 response and susceptibility has been de-
scribed to be associated with a Th2 response, notably, because
BALB/c mice display reduced control of infection compared with
that displayed by C57BL/6 mice (4, 19). BALB/c mice are well-
known for their Th2 bias in several infection models, such as the
Leishmania major infection model (41–43). The recent discovery
of the Th17 response and its implication in the control of infection
FIG 1 Course of B. melitensis infection in the spleen of C57BL/6 (B6) versus
RAG/, MyD88/, TAP-1/, MHC-II/, and MuMT/ mice. Wild-
type (WT) and deficientmicewere injected i.p. with 4 104CFUofB.meliten-
sis and sacrificed at the indicated times. The data represent the number of CFU
per gram of spleen. Gray bars represent the medians. These results are repre-
sentative of two independent experiments. *, P 0.05; **, P 0.01; ***, P
0.001.
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by several intracellular bacteria have sparked debate on the role of
each subclass of Th response during the course of Brucella infec-
tion.
In order to identify the response profile dominating Brucella
infection in C57BL/6 and BALB/c mice, we compared the expres-
sion of IFN-, IL-4, and IL-17A by quantitative real-time PCR in
spleen at 5 and 12 days p.i. (Fig. 3). As for the flow cytometry
analysis, this test was performed on the entire organ without in
vitro stimulation or purification of the spleen cells. As expected,
IFN-mRNA was indeed detected in C57BL/6 and BALB/c mice
and peaked at 5 days p.i. Both IL-4 and IL-17AmRNA expression
remained weakly detectable during infection, and only IL-17A
expression displayed a small and short upregulation at 5 days p.i.
No statistically significant differences were observed between
C57BL/6 and BALB/c mice. Thus, as determined by quantitative
RT-PCR, BALB/c mice do not seem to present a Th2 bias follow-
ing Brucella infection.
Ablationof theTh2orTh17 response doesnot affect the con-
trol ofBrucellamelitensis infection inC57BL/6mice. In order to
functionally compare the impact of each subclass of Th response,
we compared the susceptibility of C57BL/6 mice genetically defi-
cient for IL-12p35 (Th1), IL-12p40 (Th1 and Th17), IL-4 (Th2),
and IL-17R, IL-21R, and IL-22 (Th17). Mice were infected, and
bacterial counts in the spleen were examined at 5, 12, and 28 days
FIG 2 Flow cytometry analysis of IFN--producing spleen cells following B.
melitensis infection. Wild-type, RAG/, TAP-1/, MHC-II/, and
MuMT/C57BL/6 mice were injected i.p. with PBS (as a control) or 4 104
CFU of B. melitensis and sacrificed at the indicated times. Spleen cells were
harvested and analyzed by flow cytometry. Cells were gated according to size
and scatter to exclude dead cells and debris from the analysis. Spleen cells from
individual mice were first analyzed for forward size scatter (FSC) versus IFN-
production and then for cell surfacemarkers. The frequency of IFN--positive
cells in uninfected deficientmice was similar to the one observed in uninfected
wild-type mice. (A) Number of IFN--positive cells per 1.5 106 spleen cells
acquired. Each piece of data represents the value obtained from an individual
spleen, and the data are representative of two independent experiments. Gray
bars represent the medians. cont, control; *, P  0.05; ***, P  0.001. (B)
IFN--positive cells in each groupwere then analyzed forCD3,CD4,CD8, and
NK1.1 expression. The data represent themean	 SEM of groups described in
panel A. (C) The percentages of IFN--positive cells 12 days p.i. are repre-
sented in a sectoral diagram according to cell surface markers.
FIG3 Kinetics of IFN-, IL-4, and IL-17A gene expression in spleen cells from
C57BL/6 or BALB/cmice during the course of B. melitensis infection. C57BL/6
and BALB/c mice were injected i.p. with PBS (control) or 4  104 CFU B.
melitensis. After the indicated times, spleen cells were collected and total RNA
was extracted and analyzed by real-time PCR. mRNA levels were normalized
using-actinmRNAas the reference and comparedwith those obtainedunder
uninfected conditions (control). The data are expressed as themean	 SEMof
16 animals per time point pooled from two independent experiments.
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p.i. (Fig. 4A and B). Only IL-12p35/ and IL-12p40/ mice
displayed significantly higher bacterial counts thanwild-typemice
at each time point after infection, confirming the crucial role of
the Th1 response in the control of Brucella infection. Surprisingly,
IL-4 deficiency only slightly but significantly improved the resis-
tance of C57BL/6 mice at 28 days p.i. (Fig. 4A). Mice deficient for
elements (IL-17R, IL-21R, IL-22) of the Th17 response con-
trolled the infection like wild-typemice, suggesting nomajor pos-
itive role for the Th17 response (Fig. 4B).
Flow cytometry analyses of the frequency of IFN- cells in the
spleen during the course of B. melitensis infection confirm the
close relationship existing between resistance to infection and
IFN- production by CD4 T cells (Fig. 5A to D). As expected,
IL-12p35 and IL-12p40 deficiency strongly decreased the fre-
quency of IFN- cells at 5 and 12 days p.i. compared with that in
wild-type mice (Fig. 5A and B). IL-4, IL-17R, IL-21R, and IL-22
deficiency (Fig. 5C and D) affected this frequency very moder-
ately, suggesting that the Th2 andTh17 responses have onlyminor
effects on the Th1 immune response againstB.melitensis infection
in C57BL/6 mice.
In order to better identify the signal required to induce IFN-
production during Brucella infection, we compared the frequency
of IFN--producing cells in the spleen of CD28/, CD40/,
MyD88/, and IL-12p35/C57BL/6 infectedmice. MyD88/
and IL-12p35/ mice were used as internal controls. The re-
sults (see Fig. S3 in the supplemental material) showed that
deficiency of both CD28 and CD40 has only a minor impact on
the frequency of IFN--producing cells in the spleen, suggest-
ing that the MyD88 and IL-12 pathways remain the main tested
pathways regulating IFN- production during Brucella infec-
tion.
Ablationof theTh2 responsedoesnot improve the resistance
of BALB/c mice to Brucella melitensis infection. We then com-
pared the susceptibility of wild-type, IL-12p40/ (Th1 and
Th17), and IL-4R/ (Th2) BALB/c mice. As expected, IL-12p40
deficiency drastically reduced the resistance of BALB/c mice (Fig.
6), demonstrating that the Th1 response, even in this strain, is the
main protective response. Surprisingly, IL-4R deficiency did not
enhance the resistance of BALB/c mice at 5 and 12 days p.i. (Fig.
6). Only a very modest improvement of CFU counts in the spleen
was observable at 28 days p.i.
Analysis of IFN--producing cell frequency by flow cytometry
(Fig. 7A and B) showed a strong defect of IFN- production in
IL-12p40/mice. In contrast to C57BL/6 mice, IL-4R deficiency
in BALB/cmice was associated with an enhanced Th1 response, as
shown by the 2-fold higher number of IFN- cells at 5 days p.i.
However, this higher frequency was not maintained until 12 days
(Fig. 7A and B) and was not associated with better control of the
infection at the same time point (Fig. 6).
DISCUSSION
Brucellae are exquisitely well adapted to their mammalian hosts.
They disseminate in all tissues and escape many immune system
components through stealthy intracellular growth (46). However,
this silent infection leads to a chronic febrile disease with poten-
tially serious complications over the long term (12, 15, 23, 56).
Empirical research has failed to develop a safe protective vaccine
for humans (54, 59). Killed vaccines are not protective, and the
live attenuated vaccines used in animals are too virulent for hu-
mans. One solution could be subunit vaccination candidates in-
cluding Brucella antigens associated with adjuvants that mimic
patterns of pathogenesis (POPs) in order to select appropriate
immune effectormechanisms. POPs are defined as a combination
of signals including the production of pathogen-associated mo-
lecular patterns (PAMPs) and damage-associated molecular pat-
terns (DAMPs) under specific infection conditions (69). Charac-
terization ofBrucella-specific POPs requires good knowledge of its
in vivo infectious strategy, which, unfortunately, is still largely
enigmatic. Using the same mouse model, we recently character-
ized (11) macrophages and dendritic cells as the major infected
cells in the spleen and liver and identified granuloma formation as
a main trait of resistance to Brucella infection in situ. Strikingly,
the construction of granuloma structures during the early phase of
chronic infection appeared to be largely independent of adaptive
immunity, as the same structures are observed in RAG/ mice.
In contrast, they are strictly dependent onMyD88/IL-12p35/IFN-
-mediated pathways (11). This observation could explain why
IFN- (6, 52) or IRF-1 (37) deficiency, but not RAG deficiency
FIG 4 Course of B. melitensis infection in the spleen of wild-type and Th
response-deficient C57BL/6 mice. Wild-type, IL-12p35/ (Th1), IL-
12p40/ (Th1 and Th17), IL-4/ (Th2), IL-17R/, IL-21R/, and IL-
22/ (Th17) C57BL/6mice were injected i.p. with 4 104 CFU of B.meliten-
sis and sacrificed at the indicated times. The data represent the number of CFU
per gram of spleen. Gray bars represent the medians. These results are repre-
sentative of three independent experiments. *, P 0.05; **, P 0.01; ***, P
0.001.
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(29), is fatal to Brucella-infected mice. Indeed, in RAG/ mice,
NK cells produce high counts of IFN-, as shown in this work.
Though adaptive immunity components are not crucial to sur-
vival of Brucella infection, they do play a key role in successful
vaccination. Depending on the studies considered, their roles ap-
pear to be very controversial (3).
We first attempted to determine if the control of B. melitensis
infection involves a humoral immune response (circulating antibod-
ies andBcells). Several groupshavepreviouslyanalyzed thisquestion,
with contradictory results. Natural antibodies have been reported to
favor Brucella control by facilitating its elimination by phagocytosis
(61).Many serumtransfer experiments havedemonstrated apositive
role of antibodies in protectingmice againstBrucella infection (1, 50,
72). However, as previously reported by Goenka et al. (24), we ob-
served here that MuMT/ mice cleared the infection from the
spleen more rapidly than wild-type mice and displayed a higher fre-
quencyof IFN--producingTcells at thepeakof infection.Enhanced
IFN- production could be due to a regulatory role of B cells, as
hypothesized by Goenka et al. (24). On the whole, these results
strongly suggest that natural or induced humoral immunity does not
contribute positively to the control of primary Brucella infection,
without excluding a possible protective role for specific antibodies in
the secondary immune response.
FIG 6 Course of B. melitensis infection in the spleen of wild-type and Th
response-deficient BALB/c mice. Wild-type, IL-12p40/ (Th1 and Th17),
and IL-4R/ (Th2) BALB/c mice were injected i.p. with 4  104 CFU of B.
melitensis and euthanized at the indicated times. The data represent the num-
ber of CFU per gram of spleen. Gray bars represent the medians. These results
are representative of two independent experiments. *, P 0.05; **, P 0.01;
***, P 0.001.
FIG 5 Flow cytometry analysis of IFN--producing spleen cells following B. melitensis infection. Wild-type, IL-12p35/, IL-12p40/, IL-4/, IL-17R/,
IL-21R/, and IL-22/ C57BL/6 mice were injected i.p. with PBS (control) or 4 104 CFU of B. melitensis and sacrificed at the indicated times. Spleen cells
were collected and analyzed by flow cytometry. Cells were gated according to size and scatter to exclude dead cells and debris from analysis. Spleen cells from
individual mice were first analyzed for forward size scatter versus IFN- production and then for cell surface markers. The frequency of IFN--positive cells in
uninfected deficientmicewas similar to the one observed in uninfectedwild-typemice. (A, C)Number of IFN--positive cells per 1.5 106 spleen cells acquired.
(B, D) IFN--positive cells were then analyzed for T cell receptor  (TCR) and CD4 expression. The data represent the number of IFN-, T cell receptor
-positive, and CD4 cells from the groups described in panels A and B. Each piece of data represents the value obtained from an individual spleen. These data
are representative of two independent experiments. Gray bars represent the medians. *, P 0.05; **, P 0.01; ***, P 0.001.
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The precise roles of CD4 and CD8 T cells during Brucella in-
fection remain particularly unclear (reviewed in reference 3). Indeed,
a positive role for CD8 T cells in protection has been shown by
adoptive transfer (1), depletion with anti-CD8 monoclonal anti-
bodies (48, 51, 58), and infection of 2-microglobulin
/mice (52,
55). In contrast, a negative role for CD8 T cells has also been re-
ported in studies (24, 52) showing that 2-microglobulin
/ mice
cleared the infection better than their wild-type counterparts. On the
other hand, the importance of CD4 T cells has also been demon-
strated by adoptive transfer (1) and, recently, by infecting MHC-
II/mice (24). Finally, a studyusingmixed infectionwithB. abortus
2308 and the virB mutant showed no impact of 2-microglobulin
deficiencyon the control ofwild-typebacterial infectionandagreater
ability to control this infection for CD4/mice (60). These contra-
dictory results can be explained by multiple parameters, such as the
mouse and Brucella strains and the experimental design used. For
example, studies showing a central role for CD8 T cells and no
implication of CD4 T cells in 2-microglobulin
/ and MHC-
II/ mice used Brucella abortus S19 (55), which is an attenuated
strain of Brucella abortus known to be more susceptible to rapid in-
traphagocyte destruction after opsonization than a virulent strain
(17). In depletion experiments, results must be interpreted cau-
tiously, as inaccurate data can be generated by the administration
procedure or a lack of specificity of the antibodies used. For example,
the anti-CD8 antibodies used to deplete CD8 T cells also target
both CD8-positive dendritic cells and a particular subset of 
 T
cells (8).Discrepancies canalso result fromthechoiceof inadequately
or poorly characterized deficient mice. Indeed 2-microglobulin
/
mice are now known to lack CD8 T cells but also CD1d-restricted
NK T cell responses and circulating IgG antibodies (35), findings
which render interpretation of the results in the context of infection
veryhazardous.Moreover, comparisonof studiesusingexperimental
animals performed in different laboratories has raised new concerns
since environment and diet as well as immune deficiencies (22) have
been demonstrated to shape the gutmicrobiota ofmice and strongly
modify the immune response. However, the impact of immune de-
ficiencies appears to be strongly reduced under homeostatic condi-
tions (67). In agreement, we initially workedwithmice coming from
different animal facilities, and we observed significant discrepancies
following infection, even between wild-type mice that originated
from the same supplier. As a consequence, the present study com-
pared wild-type mice with a large panel of deficient mice that were
bred in the same animal facilities for a minimum of 1 year and that
thus displayed similar hygienic status. These factors and conditions
therefore bring more consistent results on the role of multiple com-
ponents of adaptive immunity.
Here, we chose to compare infection in TAP-1/ and MHC-
II/ C57BL/6 mice to evaluate the contribution of CD8 and
CD4 T cell functions, respectively. Both types of deficient mice
were able to control bacterial growth at the peak of infection.
Although transient susceptibility was observed in both groups of
mice by 12 days p.i., TAP-1/ mice were able to control the
infection at 28 days p.i. In contrast, MHC-II/mice displayed a
10-fold increased bacterial load at 28 days p.i., suggesting a pro-
tective role for MHC-II-dependent CD4 T cells during the
chronic phase of infection. IFN- was produced by both CD4
and CD8 T cells at the peak of infection (5 days p.i.), but only
CD4 T cells retained the ability to produce high levels of IFN-
during the plateau phase of infection in wild-type mice (10; this
study). It is very interesting to note that the frequency of IFN--
producing cells wasmaintained at similar levels during the plateau
phase of infection in both MHC-II/ and TAP-1/ mice. In
MHC-II/ mice, IFN- production was restricted to CD8 T
cells, showing that these cells were able to sustain IFN- produc-
tion for more than 5 days. However, these cells did not provide
protection since MHC-II/ mice displayed enhanced CFU
counts in the spleen compared with TAP-1/ and wild-type
mice. While several studies (4, 19, 52) support a correlation be-
tween IFN- production and protection, our data demonstrate
that IFN- production must be associated with activated CD4 T
cells to be protective, suggesting that CD4 T cells provide other
undetermined additional protective cofactors.
The protective immune response against Brucella has histori-
cally been associated with the Th1 response, notably, because
BALB/c mice, which display a well-known Th2 bias in several in-
FIG 7 Flow cytometry analysis of IFN--producing cells following B. meliten-
sis infection. Wild-type, IL-12p40/, and IL-4R/ BALB/c mice were in-
jected i.p. with PBS (control) or 4 104 CFU of B. melitensis and sacrificed at
the indicated times. Spleen cells were collected and analyzed by flow cytom-
etry. Cells were gated according to size and scatter to exclude dead cells and
debris from analysis. Spleen cells from individual mice were first analyzed for
forward size scatter versus IFN- production and then for cell surfacemarkers.
The frequency of IFN--positive cells in uninfected deficient mice was similar
to the one observed in uninfected wild-type mice. (A) Number of IFN--
positive cells per 1.5 106 spleen cells acquired. (B) IFN--positive cells were
analyzed for T cell receptor (TCR) and CD4 expression. The data represent
the number of IFN-, T cell receptor -positive, and CD4 cells from the
groups described in panel A. Each piece of data represents the value obtained
from an individual spleen, and the data are representative of two independent
experiments. Gray bars represent the medians. ***, P 0.001.
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fectionmodels (42, 43), show a reduced ability to control Brucella
infection compared with C57BL/6 mice (4, 19). It has been hy-
pothesized (19) that production of IL-4 in BALB/c mice reduces
the production of IFN- and adversely affects the protective im-
mune response to Brucella. Our data showed that infected
C57BL/6 and BALB/c mice displayed similar weak expression of
IL-4 mRNA in the spleen. Along the same lines, in BALB/c and
C57BL/6 mice, the absence of IL-4 protein detectable by enzyme-
linked immunosorbent assay following in vitro restimulation has
been reported previously (19). Using IL-4/ C57BL/6 and IL-
4R/ BALB/c mice, we demonstrate that IL-4 does not adversely
affect host defense against Brucella infection. Indeed, IL-4 defi-
ciency in C57BL/6 mice did not drastically enhance IFN- pro-
duction. However, in IL-4R/ BALB/c mice, a 2-fold increase in
IFN- production was measurable at the peak of infection. This
difference could be a consequence of the lack of responsiveness to
both IL-4 and IL-13 in IL-4R/ mice (32). Thus, we conclude
that the low levels of IL-4 produced during Brucella infection in
wild-type C57BL/6 and BALB/c mice do not affect the ability to
mount a protective response. These observations support the idea,
previously suggested by others (62), that the susceptibility of
BALB/cmice toBrucella infection is not due to the development of
a Th2 response but is due to an intrinsically lower ability tomount
a Th1 response.
The recently characterized Th17 response has been shown to
contribute to host defense against several extracellular pathogens,
such asKlebsiella pneumoniae (26, 73),Citrobacter rodentium (45),
and Candida albicans (28), as well as against intracellular micro-
organisms, such as Listeria monocytogenes, Salmonella enterica,
and Mycobacterium tuberculosis (14, 33, 68). The role of Th17
during Brucella infection has not been extensively explored. Two
studies have reported that IL-17A neutralization (57) or the ab-
sence of IL-17R (65) did not at all influence the subsistence and
growth of Brucella at 1 month and 1 week postinfection, respec-
tively. However, another recent study has demonstrated a role for
IL-17-producing T cells in osteoclastogenesis during murine bru-
cellosis (21). The Th17 response implicates the coordinated pro-
duction of IL-17, IL-21, and IL-22 byCD4Tcells following IL-23
secretion by antigen-presenting cells (for a review, see reference
5). In this study, we compared the ability of wild-type, IL-
12p35/, IL-12p40/ (IL-12/23/), IL-17R/, IL-21/,
and IL-22/ mice to control Brucella infection. Only IL-
12p35/ and IL-12p40/ mice displayed susceptibility to Bru-
cella infection, suggesting that components of the Th17 response
are not essential to bacterial clearance. However, we observed sig-
nificant transitory higher susceptibility in IL-12p40/mice than
IL-12p35/mice. This difference suggests cooperation between
the Th1 and Th17 responses during Brucella infection. A similar
phenomenon during Mycobacterium tuberculosis infection has
been reported previously (9, 34). When IL-12p70 is available,
IL-23 is dispensable for protection. In the absence of IL-12p70, the
lack of IL-23 enhanced susceptibility to M. tuberculosis. These
compensations have also been described for Salmonella enterica
(63) and Toxoplasma gondii (40).
In summary, our study demonstrates the key role played by
IFN--producing Th1 CD4 T cells in the control of Brucella
infection and the negligible importance of CD8 T cells or hu-
moral immunity in the clearance of bacteria during primary in-
fection. We also showed that an IL-4-dependent Th2 response
does not develop or play a negative role during the course of in-
fection. However, the Th17 response could partially compensate
for the lack of a Th1 response. These results could potentially
improve our ability to develop a protective vaccine or therapeutic
treatment against brucellosis. They suggest that favoring IL-12
production during Brucella vaccination, for example, by targeting
CD8 dendritic cells, should lead to a better induction and per-
sistence of IFN--producing CD4 T cells and concomitantly al-
low better protection against Brucella infection.
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